Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers.

Peripheral blood lymphocytes from 14 adult male patients admitted to the hospital with complications of intravenous drug abuse (IDA) were examined for natural killer (NK) and antibody-dependent cellular cytotoxic (ADCC) activities, lectin-dependent cellular cytotoxicity, and interferon (IFN)- and interleukin 2 (IL-2)-induced NK activity. Serum was also assayed for circulating interferon levels and soluble factor(s) capable of suppressing the cytotoxic potential of allogeneic lymphocytes from healthy donors. IDA patients demonstrated significantly decreased levels of NK and ADCC activities compared to age- and sex-matched healthy controls. The lectin, phytohemagglutinin, could significantly enhance the cytotoxicity of IDA lymphocytes; however, activity was not completely restored to normal levels. IDA sera demonstrated a significant inhibitory effect on the NK and ADCC activities of normal allogeneic lymphocytes, and these sera contained negligible levels of circulating IFN. Although the NK activity of IDA lymphocytes could not be restored completely to normal levels by either IFN-alpha or IL-2, the percentage enhancement of cytotoxicity was remarkably higher in IDA patients with significantly reduced NK activity than that observed using PBL from patients with near normal NK activity. The ability of IFN or IL-2 to enhance the decreased cytotoxicity of PBL from drug abusers suggests a novel therapeutic approach to the management of the complications of IDA.
AuthorsM P Nair, T J Laing, S A Schwartz
JournalClinical immunology and immunopathology (Clin Immunol Immunopathol) Vol. 38 Issue 1 Pg. 68-78 (Jan 1986) ISSN: 0090-1229 [Print] UNITED STATES
PMID3484438 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Interferon Type I
  • Interleukin-2
  • Acquired Immunodeficiency Syndrome (immunology)
  • Adult
  • Antibody-Dependent Cell Cytotoxicity
  • Humans
  • Injections, Intravenous (adverse effects)
  • Interferon Type I (blood, pharmacology)
  • Interleukin-2 (physiology)
  • Killer Cells, Natural (immunology)
  • Male
  • Middle Aged
  • Substance-Related Disorders (complications, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: